2011
DOI: 10.1590/s1677-55382011000200004 View full text |Buy / Rent full text
|
|

Abstract: Purpose: Metastatic renal cell carcinoma (RCC) is one of the most treatment-resistant malignancies and nephrectomy, isolated or combined with systemic chemotherapy typically has limited or no effectiveness. We report our initial results in patients treated with the association of molecular targeted therapy, nephrectomy, and hybrid dendritic-tumor cell (DC) vaccine. Materials and Methods:Two male patients diagnosed with metastatic RCC were selected for the study. They were treated with the triple strategy, in w… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
2
0

Publication Types

Select...

Relationship

0
0

Authors

Journals